Basaglar

Active Ingredient(s): Insulin Glargine
FDA Approved: * December 16, 2015
Pharm Company: * ELI LILLY AND CO
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Basaglar Overview

Insulin glargine, marketed under the names Lantus, among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert). Pharmacokinetically, its steady action can supplement the variable insulin secretion of non-diabetic pancreatic beta cells. ...

Read more Basaglar Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Insulin_glargine

Recent Basaglar Forums: RSS Feed

Invocana, Victosa and Basaglar negative reactions

I am a type 2 diabetic and I'm taking other diabetic meds along with Invocana. I'm taking other meds, such as Basaglar, and Victosa. Do these drugs interact negatively with the other diabetic drugs I'm taking? ## Hello Ladd, I was able to find 2 interactions between the medicines you listed. I have put both of them below. Basaglar (insulin glargine) -> Victoza (liraglutide) Using liraglutide together with insulin glargine can increase the risk of hypoglycemia, or low blood sugar. Let your doctor know if you experience hypoglycemia during treatment. Symptoms of hypoglycemia include headache, dizziness, drowsiness, nervousness, confusion, tremor, nausea, hunger, weakness, perspiration, palpitation, and rapid heartbeat. Basaglar (insulin glargine) -> Invokana (canaglifl...

Updated

Possible Dosages for this and Related Drugs:

Insulin Glargine
  • Injection: 100 Units/ml, 100unit/ml, 300 Units/ml
  • Solution: 300 Units/3ml (100 Units/ml), 300 Units/ml (300 Units/ml), 300units/ml (300units/ml), 450 Units/1.5ml (300 Units/ml), 900 Units/3ml (300 Units/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Basaglar: (2 results)

Sorted by National Drug Code
  • 0002-7711 Basaglar 100 [Iu]/Ml Subcutaneous Injection, Solution by Eli Lilly and Company
  • 0002-7715 Basaglar 100 [Iu]/Ml Subcutaneous Injection, Solution by Eli Lilly and Company

Other drugs which contain Insulin Glargine or a similar ingredient: (4 results)

Related Basaglar Topics:

Invocana, Victosa and Basaglar negative reactions
I am a type 2 diabetic and I'm taking other diabetic meds along with Invocana. I'm taking other meds, such as Ba... 1 reply






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA